Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1974 3
1975 1
1976 3
1977 6
1978 10
1979 4
1980 4
1981 3
1982 3
1983 3
1984 1
1985 1
1986 1
1987 1
1988 3
1989 3
1990 6
1991 5
1992 6
1993 1
1994 4
1995 4
1996 1
1997 6
1998 7
1999 9
2000 12
2001 4
2002 4
2003 7
2004 9
2005 5
2006 6
2007 5
2008 4
2009 3
2010 7
2011 9
2012 6
2013 4
2014 8
2015 13
2016 8
2017 12
2018 8
2019 24
2020 12
2021 19
2022 17
2023 18
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Results by year

Filters applied: . Clear all
Page 1
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Mirza MR, Chase DM, Slomovitz BM, dePont Christensen R, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Hanker LC, Stuckey A, Boere I, Gold MA, Auranen A, Pothuri B, Cibula D, McCourt C, Raspagliesi F, Shahin MS, Gill SE, Monk BJ, Buscema J, Herzog TJ, Copeland LJ, Tian M, He Z, Stevens S, Zografos E, Coleman RL, Powell MA; RUBY Investigators. Mirza MR, et al. N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27. N Engl J Med. 2023. PMID: 36972026 Clinical Trial.
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ; PRIMA/ENGOT-OV26/GOG-3012 Investigators. González-Martín A, et al. N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562799 Clinical Trial.
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
Pötter R, Tanderup K, Schmid MP, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Ristl R, Petric P, Nesvacil N, Kirchheiner K, Kirisits C, Lindegaard JC; EMBRACE Collaborative Group. Pötter R, et al. Lancet Oncol. 2021 Apr;22(4):538-547. doi: 10.1016/S1470-2045(20)30753-1. Lancet Oncol. 2021. PMID: 33794207 Clinical Trial.
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Mirza MR, Åvall Lundqvist E, Birrer MJ, dePont Christensen R, Nyvang GB, Malander S, Anttila M, Werner TL, Lund B, Lindahl G, Hietanen S, Peen U, Dimoula M, Roed H, Ør Knudsen A, Staff S, Krog Vistisen A, Bjørge L, Mäenpää JU; AVANOVA investigators. Mirza MR, et al. Among authors: anttila m. Lancet Oncol. 2019 Oct;20(10):1409-1419. doi: 10.1016/S1470-2045(19)30515-7. Epub 2019 Aug 29. Lancet Oncol. 2019. PMID: 31474354 Clinical Trial.
Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT, Nout R, Nesvacil N, de Leeuw A, Pötter R, Kirisits C; EMBRACE Collaborative Group. Schmid MP, et al. J Clin Oncol. 2023 Apr 1;41(10):1933-1942. doi: 10.1200/JCO.22.01096. Epub 2023 Jan 4. J Clin Oncol. 2023. PMID: 36599120
[Ovarian cysts].
Kuivasaari-Pirinen P, Anttila M. Kuivasaari-Pirinen P, et al. Among authors: anttila m. Duodecim. 2011;127(17):1857-63. Duodecim. 2011. PMID: 21995122 Finnish.
Hyaluronan in human malignancies.
Sironen RK, Tammi M, Tammi R, Auvinen PK, Anttila M, Kosma VM. Sironen RK, et al. Among authors: anttila m. Exp Cell Res. 2011 Feb 15;317(4):383-91. doi: 10.1016/j.yexcr.2010.11.017. Epub 2010 Dec 3. Exp Cell Res. 2011. PMID: 21134368 Review.
Design and Application of Sensors for Chemical Cytometry.
Vickerman BM, Anttila MM, Petersen BV, Allbritton NL, Lawrence DS. Vickerman BM, et al. Among authors: anttila mm. ACS Chem Biol. 2018 Jul 20;13(7):1741-1751. doi: 10.1021/acschembio.7b01009. Epub 2018 Feb 8. ACS Chem Biol. 2018. PMID: 29376326 Free PMC article. Review.
Pharmacokinetics of toremifene.
Anttila M, Valavaara R, Kivinen S, Mäenpää J. Anttila M, et al. J Steroid Biochem. 1990 Jun 22;36(3):249-52. doi: 10.1016/0022-4731(90)90019-o. J Steroid Biochem. 1990. PMID: 2142247
Pneumococcal conjugate vaccines.
Eskola J, Anttila M. Eskola J, et al. Among authors: anttila m. Pediatr Infect Dis J. 1999 Jun;18(6):543-51. doi: 10.1097/00006454-199906000-00015. Pediatr Infect Dis J. 1999. PMID: 10391188 Review. No abstract available.
298 results